Cleared Traditional

K181445 - AMSure Hydrophilic Intermittent Catheter (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
122d
Days
Class 2
Risk

K181445 is an FDA 510(k) clearance for the AMSure Hydrophilic Intermittent Catheter. Classified as Catheter, Straight (product code EZD), Class II - Special Controls.

Submitted by Amsino International, Inc. (Pomona, US). The FDA issued a Cleared decision on October 1, 2018 after a review of 122 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5130 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Amsino International, Inc. devices

Submission Details

510(k) Number K181445 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 01, 2018
Decision Date October 01, 2018
Days to Decision 122 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 130d · This submission: 122d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code EZD Catheter, Straight
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - EZD Catheter, Straight

All 80
Devices cleared under the same product code (EZD) and FDA review panel - the closest regulatory comparables to K181445.
LoFric Elle Pro
K260999 · Wellspect AB · Apr 2026
GentleCath Air for Men
K252943 · Convatec Limited · Apr 2026
Liv Pre-lubricated Intermittent Catheter
K260502 · HR Healthcare · Mar 2026
EZ-Protect Hydrophilic Closed System Intermittent Catheter
K251274 · HR Healthcare · Jan 2026
Ready to use Nelaton Catheter
K251178 · Jamjoom Fullcare Corporation · Jan 2026
Sleeved IC 3 Family Sleeved IC 3 SWT (name not finalized) Sleeved IC 3 Pocket (name not finalized) Sleeved IC 3 Plus (name not finalized) Sleeved IC 3 Plus Pocket (name not finalized) (N/A)
K251468 · Hollister Incorporated · Oct 2025